Robert Hoffman - Net Worth and Insider Trading

Robert Hoffman Net Worth

The estimated net worth of Robert Hoffman is at least $245,710 dollars as of 2024-04-24. Robert Hoffman is the SVP, Finance and CFO of Arena Pharmaceuticals Inc and owns about 1,957 shares of Arena Pharmaceuticals Inc (ARNA) stock worth over $195,680. Robert Hoffman is the Director of CombiMatrix Corp and owns about 7,409 shares of CombiMatrix Corp (CBMX) stock worth over $46,306. Robert Hoffman is also the CFO & SVP, Finance of Heron Therapeutics Inc and owns about 1,280 shares of Heron Therapeutics Inc (HRTX) stock worth over $3,578. Besides these, Robert Hoffman also holds Kintara Therapeutics Inc (KTRA) . Details can be seen in Robert Hoffman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Hoffman has not made any transactions after 2022-02-15 and currently still holds the listed stock(s).

Transaction Summary of Robert Hoffman

To

Robert Hoffman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Robert Hoffman owns 8 companies in total, including Kintara Therapeutics Inc () , Kura Oncology Inc () , and Aravive Inc () among others .

Click here to see the complete history of Robert Hoffman’s form 4 insider trades.

Insider Ownership Summary of Robert Hoffman

Ticker Comapny Transaction Date Type of Owner
Kintara Therapeutics Inc 2022-02-15 director & President and CEO
Kura Oncology Inc 2015-03-17 director
Aravive Inc 2019-09-12 director
Heron Therapeutics Inc 2018-07-02 CFO & SVP & Finance
CombiMatrix Corp 2017-11-14 director
MabVax Therapeutics Holdings Inc 2017-05-19 director
Innovus Pharmaceuticals Inc 2016-09-06 Chief Financial Officer
Arena Pharmaceuticals Inc 2014-12-15 SVP & Finance and CFO

Robert Hoffman Latest Holdings Summary

Robert Hoffman currently owns a total of 4 stocks. Among these stocks, Robert Hoffman owns 1,957 shares of Arena Pharmaceuticals Inc (ARNA) as of April 1, 2013, with a value of $195,680 and a weighting of 79.64%. Robert Hoffman owns 7,409 shares of CombiMatrix Corp (CBMX) as of May 10, 2016, with a value of $46,306 and a weighting of 18.85%. Robert Hoffman also owns 1,280 shares of Heron Therapeutics Inc (HRTX) as of July 2, 2018, with a value of $3,578 and a weighting of 1.46%. The other 1 stocks Kintara Therapeutics Inc (KTRA) have a combined weighting of 0.06% among all his current holdings.

Latest Holdings of Robert Hoffman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ARNA Arena Pharmaceuticals Inc 2013-04-01 1,957 99.99 195,680
CBMX CombiMatrix Corp 2016-05-10 7,409 6.25 46,306
HRTX Heron Therapeutics Inc 2018-07-02 1,280 2.80 3,578
KTRA Kintara Therapeutics Inc 2022-02-15 1,100 0.13 146

Holding Weightings of Robert Hoffman


Robert Hoffman Form 4 Trading Tracker

According to the SEC Form 4 filings, Robert Hoffman has made a total of 0 transactions in Arena Pharmaceuticals Inc (ARNA) over the past 5 years. The most-recent trade in Arena Pharmaceuticals Inc is the sale of 7,125 shares on April 1, 2013, which brought Robert Hoffman around $584,962.

According to the SEC Form 4 filings, Robert Hoffman has made a total of 0 transactions in CombiMatrix Corp (CBMX) over the past 5 years. The most-recent trade in CombiMatrix Corp is the acquisition of 5,000 shares on May 10, 2016, which cost Robert Hoffman around $15,950.

According to the SEC Form 4 filings, Robert Hoffman has made a total of 0 transactions in Heron Therapeutics Inc (HRTX) over the past 5 years. The most-recent trade in Heron Therapeutics Inc is the sale of 30,000 shares on July 2, 2018, which brought Robert Hoffman around $1 Million.

More details on Robert Hoffman's insider transactions can be found in the Insider Trading History of Robert Hoffman table.

Insider Trading History of Robert Hoffman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Robert Hoffman Trading Performance

GuruFocus tracks the stock performance after each of Robert Hoffman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Hoffman is -23.29%. GuruFocus also compares Robert Hoffman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Hoffman within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Robert Hoffman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Robert Hoffman

Average Return

7.22%

Average return per transaction

Outperforming Transactions

50%

1 out of 2 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -20.48 -23.29 -43.42 7.22 -93.22
Relative Return to S&P 500(%) -18.43 -20.48 -43.47 3.28 -99.28

Robert Hoffman Ownership Network

Ownership Network List of Robert Hoffman

No Data

Ownership Network Relation of Robert Hoffman


Robert Hoffman Owned Company Details

What does Kintara Therapeutics Inc do?

Who are the key executives at Kintara Therapeutics Inc?

Robert Hoffman is the director & President and CEO of Kintara Therapeutics Inc. Other key executives at Kintara Therapeutics Inc include Chief Financial Officer Anthony Scott Praill , director & Head of Strategic Partnerships Saiid Zarrabian , and Chief Scientific Officer Dennis M Brown .

Kintara Therapeutics Inc () Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Kintara Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kintara Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Kintara Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kintara Therapeutics Inc Insider Transactions

No Available Data

Robert Hoffman Mailing Address

Above is the net worth, insider trading, and ownership report for Robert Hoffman. You might contact Robert Hoffman via mailing address: Arena Pharmaceuticals Inc, 6166 Nancy Rider Drive, San Diego Ca 92121.

Discussions on Robert Hoffman

No discussions yet.